CORDIS
EU research results

CORDIS

English EN

Training European Experts in Multiscale Studies of Neural Crest Development and Disorders: from Patient to Model Systems and Back again.

Project information

Grant agreement ID: 860635

Status

Ongoing project

  • Start date

    1 November 2019

  • End date

    31 October 2023

Funded under:

H2020-EU.1.3.1.

  • Overall budget:

    € 4 156 404,84

  • EU contribution

    € 4 156 404,84

Coordinated by:

INSTITUT CURIE

France

Project description

English EN

Understanding regulation of embryonic cells could shed light on numerous pathologies

Neural crest cells are a transient group of embryonic cells that migrate extensively, giving rise not only to most of the peripheral nervous system but also to cells of the adrenal gland, smooth muscle cells of the cardiovascular system, pigment cells in the skin, and craniofacial bones, cartilage, and connective tissue. Neurocristopathies (NCP) result from abnormalities in neural crest cells, and cancers such as melanoma and neuroblastoma are linked to them. However, it is difficult to trace pathologies to specific mutations in these cells. NEUcrest is harnessing the power of early stage researchers to tease out the complex aspects of neural cell and tumour formation, and more generally, the regulation of neural cell tissue in human health.

Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

INSTITUT CURIE

Address

Rue D'Ulm 26
75231 Paris

France

Activity type

Research Organisations

EU Contribution

€ 549 604,08

Participants (10)

KING'S COLLEGE LONDON

United Kingdom

EU Contribution

€ 303 172,56

UNIVERSITY OF EAST ANGLIA

United Kingdom

EU Contribution

€ 606 345,12

NATIONAL UNIVERSITY OF IRELAND GALWAY

Ireland

EU Contribution

€ 549 368,64

UNIVERSIDAD MIGUEL HERNANDEZ DE ELCHE

Spain

EU Contribution

€ 501 809,76

ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM

Netherlands

EU Contribution

€ 265 619,88

MEDIZINISCHE UNIVERSITAET WIEN

Austria

EU Contribution

€ 264 207,24

TEL AVIV UNIVERSITY

Israel

EU Contribution

€ 263 500,92

STEMCELL TECHNOLOGIES UK LTD

United Kingdom

EU Contribution

€ 303 172,56

AZELEAD

France

EU Contribution

€ 274 802,04

IMAGINE INSTITUT DES MALADIES GENETIQUES NECKER ENFANTS MALADES FONDATION

France

EU Contribution

€ 274 802,04

Project information

Grant agreement ID: 860635

Status

Ongoing project

  • Start date

    1 November 2019

  • End date

    31 October 2023

Funded under:

H2020-EU.1.3.1.

  • Overall budget:

    € 4 156 404,84

  • EU contribution

    € 4 156 404,84

Coordinated by:

INSTITUT CURIE

France